mhurhangee/ep-ind-claims huggingface dataset:
A polyfunctional carrier device composed of biocompatible and substantially biodegradable material, suited to be conveyed within organic fluids and/or environments for carrying out at least an operative function, comprising: - a main body, composed of biocompatible and biodegradable material, in particular suited to constitute a reservoir for a substance to be administered and provided with at least an opening (13,14) for the outflow of a substance to be administered towards said organic fluids and/or environments; - actuation means (16,17;21-25,40,+,-) of at least a function of the polyfunctional carrier within organic fluids and/or environments, characterized in that it comprises, associated with the main body, magnetic means (30,31) in the form of a plurality of magnetic elements of a first type and of a plurality of magnetic elements of a second type having respectively South/North and North/South polarity oriented upwards with respect to the main body, suited to assuming a defined magnetic polarity for guiding and positioning said carrier within organic fluids and/or environments by magnetic fields operating externally to said organic fluids and/or environments, and are disposed along the outer surfaces (13,14) of the main body, suited overall to generating a magnetic field defined, polarized and directed in order to aggregate a plurality of carrier devices in a spatial configuration defined by said magnetic means (30,31). - a main body, composed of biocompatible and biodegradable material, in particular suited to constitute a reservoir for a substance to be administered and provided with at least an opening (13,14) for the outflow of a substance to be administered towards said organic fluids and/or environments; - actuation means (16,17;21-25,40,+,-) of at least a function of the polyfunctional carrier within organic fluids and/or environments,
A computer system, comprising: a configuration comprising one or more cores configurable between a single thread mode and a multithreading mode, the ST mode addressing a primary thread and the MT mode addressing the primary thread and one or more secondary threads on shared resources of each core; and a multithreading facility configured to control utilization of the configuration to perform a method comprising: executing, by a core, a retrieve multithreading capability information (RMTCI) instruction, the execution comprising: obtaining thread identification information that identifies multithreading capability of the configuration; storing the obtained thread identification information; and determining whether the configuration previously had MT enabled based on the obtained thread identification information, wherein the obtained thread information comprises a most recently set program-specified maximum thread identifier (PSMTID) of a highest thread of the configuration and wherein the PSMTID indicates how memory within the system is to be addressed. a configuration comprising one or more cores configurable between a single thread mode and a multithreading mode, the ST mode addressing a primary thread and the MT mode addressing the primary thread and one or more secondary threads on shared resources of each core; and a multithreading facility configured to control utilization of the configuration to perform a method comprising: executing, by a core, a retrieve multithreading capability information (RMTCI) instruction, the execution comprising: obtaining thread identification information that identifies multithreading capability of the configuration; storing the obtained thread identification information; and determining whether the configuration previously had MT enabled based on the obtained thread identification information, wherein the obtained thread information comprises a most recently set program-specified maximum thread identifier (PSMTID) of a highest thread of the configuration and wherein the PSMTID indicates how memory within the system is to be addressed. obtaining thread identification information that identifies multithreading capability of the configuration; storing the obtained thread identification information; and determining whether the configuration previously had MT enabled based on the obtained thread identification information, wherein the obtained thread information comprises a most recently set program-specified maximum thread identifier (PSMTID) of a highest thread of the configuration and wherein the PSMTID indicates how memory within the system is to be addressed.
A method implemented by one or more processors, the method comprising: determining that a user has provided a spoken utterance that includes requests for an automated assistant (122, 124) to perform multiple actions that include a first type of action and a second type of action, wherein the automated assistant is accessible to the user via an automated assistant interface of a computing device; generating, in response to the user providing the spoken utterance, an estimated delay for the first type of action when the second type of action is prioritized over the first type of action during execution of the multiple actions; determining, based on the estimated delay, whether the estimated delay for the first type of action satisfies a threshold, wherein, when the estimated delay for the first type of action satisfies the threshold, execution of the first type of action is prioritized over the second type of action; generating, based on whether the estimated delay satisfies the threshold, a preferred order of execution for the multiple actions requested by the user; and causing the automated assistant (122, 124) to initialize performance of the multiple actions according to the preferred order of execution. determining that a user has provided a spoken utterance that includes requests for an automated assistant (122, 124) to perform multiple actions that include a first type of action and a second type of action, wherein the automated assistant is accessible to the user via an automated assistant interface of a computing device; generating, in response to the user providing the spoken utterance, an estimated delay for the first type of action when the second type of action is prioritized over the first type of action during execution of the multiple actions; determining, based on the estimated delay, whether the estimated delay for the first type of action satisfies a threshold, wherein, when the estimated delay for the first type of action satisfies the threshold, execution of the first type of action is prioritized over the second type of action; generating, based on whether the estimated delay satisfies the threshold, a preferred order of execution for the multiple actions requested by the user; and causing the automated assistant (122, 124) to initialize performance of the multiple actions according to the preferred order of execution.
Man or woman trousers comprising: - a first and second leg portions, adapted to receive corresponding legs of a wearer; - a waist portion adapted to surround the wearer waist, - a crotch portion arranged between the first and second leg portions, extending between a front portion and a back portion (4") of the waist portion, said crotch portion being adapted to cover the genital area of the wearer; - one or more seams for connecting said crotch portion to said first leg portion and/or said second leg portion and/or said waist portion, wherein said one or more seams are arranged so that they are outside said wearer genital area when the trousers are worn by the latter, characterized in that said crotch portion is integrally formed with at least one among said waist portion, said first leg portion, and said second leg portion, said crotch portion being connected to the others among said first leg portion, said second leg portion, and said waist portion by means of said one or more seams. - a first and second leg portions, adapted to receive corresponding legs of a wearer; - a waist portion adapted to surround the wearer waist, - a crotch portion arranged between the first and second leg portions, extending between a front portion and a back portion (4") of the waist portion, said crotch portion being adapted to cover the genital area of the wearer; - one or more seams for connecting said crotch portion to said first leg portion and/or said second leg portion and/or said waist portion, wherein said one or more seams are arranged so that they are outside said wearer genital area when the trousers are worn by the latter,
A method for producing an endless belt, which has at least one fibre, which runs around in a spiral manner in the endless belt, a peripheral carrier film is provided, which has a side provided with an adhesive layer, and the at least one fibre is applied in a spiral manner to the side of the carrier film which is provided with the adhesive layer, further layers being applied to the arrangement made up of carrier film and the at least one fibre, characterized in that the further layers comprise a surface heating layer, wherein the surface heating layer is formed by a plurality of resistance heating layers arranged above one another or in an overlapping manner in the direction of longitudinal extent or the transverse direction, wherein the various resistance heating layers have different surface heating outputs.
A semiconductor manufacturing method comprising the steps of: - (a) positioning an anode in a first end of a base material and a cathode in a second end of the base material, the base material containing an aluminum oxide, the anode causing an oxidation reaction, the cathode causing a reduction reaction; - (b) heating the base material to melt the base material in a state where the anode is in contact with the first end of the base material and the cathode is in contact with the second end of the base material; - (c) causing a current to flow between the anode and the cathode to cause a molten salt electrolysis reaction for a whole of or a part of a period in which the base material is at least partially melted; and - after the step (c), (d) cooling the base material to form a p-type aluminum oxide semiconductor layer and/or an n-type aluminum oxide semiconductor layer. - (a) positioning an anode in a first end of a base material and a cathode in a second end of the base material, the base material containing an aluminum oxide, the anode causing an oxidation reaction, the cathode causing a reduction reaction; - (b) heating the base material to melt the base material in a state where the anode is in contact with the first end of the base material and the cathode is in contact with the second end of the base material; - (c) causing a current to flow between the anode and the cathode to cause a molten salt electrolysis reaction for a whole of or a part of a period in which the base material is at least partially melted; and - after the step (c), (d) cooling the base material to form a p-type aluminum oxide semiconductor layer and/or an n-type aluminum oxide semiconductor layer.
A control method of a service function chain based on Policy and Charging Control, PCC, architecture comprising a first network device, a second network device, a third network device and a service function execution unit, the method comprising the steps, performed by the first network device, of:. receiving (S210.), from the third network device (PCRF), policy rule information of an IP flow, the policy rule information including service function chain information;. receiving (S220.), from a UE, an uplink packet of the IP flow, and adding (S230.) a policy rule information header in the uplink packet of the IP flow; and. transmitting, based on the policy rule information, to the service function execution unit, the uplink IP packet in which the policy rule information header has been added; the service function execution unit being configured for performing all service functions in the policy rule information for the uplink IP packet in which the policy rule information header has been added, and transmitting, to the second network device, the uplink IP packet in which all service functions have been performed, wherein the service function chain information comprises an ordered set of all service functions of the IP flow.
A method of forming contacts for an interconnection element, comprising: (a) joining a conductive element to an interconnection element having multiple wiring layers with a dielectric layer between the conductive element and the interconnection element; (b) patterning the conductive element to form conductive pins such that at least a portion of a major surface of the dielectric layer is exposed between at least some of the pins; (c) then forming openings in the dielectric layer extending from the exposed portions of the major surface; and (d) then electrically interconnecting the conductive pins with conductive features of the interconnection element through the openings in the dielectric layer. (a) joining a conductive element to an interconnection element having multiple wiring layers with a dielectric layer between the conductive element and the interconnection element; (b) patterning the conductive element to form conductive pins such that at least a portion of a major surface of the dielectric layer is exposed between at least some of the pins; (c) then forming openings in the dielectric layer extending from the exposed portions of the major surface; and (d) then electrically interconnecting the conductive pins with conductive features of the interconnection element through the openings in the dielectric layer.
: A process for the preparation of Sugammadex or its salts, preferably Sugammadex sodium, which comprises: a) reacting 3-mercaptopropionic acid of formula with an ionic base to obtain the mono-salt of formula, wherein M is an alkaline metal; b) isolating the mono-salt of formula; c) reacting the mono-salt of formula with the compound of formula or a hydrate or solvate thereof, in the presence of an ionic base, wherein X is CI, Br, I, or OSO 2 R, wherein R is C 1 -C 4 alkyl, optionally substituted by F, Cl, Br or I; phenyl or C 1 -C 4 alkyl-phenyl. a) reacting 3-mercaptopropionic acid of formula with an ionic base to obtain the mono-salt of formula, wherein M is an alkaline metal; b) isolating the mono-salt of formula; c) reacting the mono-salt of formula with the compound of formula or a hydrate or solvate thereof, in the presence of an ionic base, wherein X is CI, Br, I, or OSO 2 R, wherein R is C 1 -C 4 alkyl, optionally substituted by F, Cl, Br or I; phenyl or C 1 -C 4 alkyl-phenyl.
An inhalation device comprising a heatable material and a formulation, wherein the formulation is a heat source which heats the heatable material in use; wherein the formulation comprises sodium acetate trihydrate, a kinetic inhibitor and a solvent; and wherein the kinetic inhibitor is selected the group consisting of: sodium carboxymethyl cellulose; gelatine; ethyl cellulose; polyethylene glycol; xanthan gum; glycerol; urea; polysorbate 20; polysorbate 80; polyacrylic acid; sodium pyrophosphate; polyacrylamide; pullulan; poly(vinyl alcohol); and poly(vinyl acetate).
A laboratory instrument for treating a biological tissue sample and for producing a reagent for use by the instrument, said instrument including: a diluent dispenser containing a diluent and configured to be operatively coupled to a concentrate chamber containing a concentrate to dispense the diluent for mixing with the concentrate on the instrument; and one or more mixing wells located on the instrument and configured to receive the concentrate and the diluent for mixing to produce the reagent at a required concentration; characterised in that the mixing well is formed in a fixed or disposable cover member of a sample staining module of the instrument, and wherein the instrument is configured to use the reagent produced for treating a biological tissue sample within the SSM. a diluent dispenser containing a diluent and configured to be operatively coupled to a concentrate chamber containing a concentrate to dispense the diluent for mixing with the concentrate on the instrument; and one or more mixing wells located on the instrument and configured to receive the concentrate and the diluent for mixing to produce the reagent at a required concentration; characterised in that the mixing well is formed in a fixed or disposable cover member of a sample staining module of the instrument, and wherein the instrument is configured to use the reagent produced for treating a biological tissue sample within the SSM.
A coated implantable medical device, comprising: a base layer comprising mTOR inhibitor, and a blend of biodegradable polymers, wherein the mTOR inhibitor concentration for the base layer is in the range of 0.6 to 2.2 μg/mm 2; a middle layer comprising mTOR inhibitor, and a blend of biodegradable polymers,_wherein the mTOR inhibitor concentration for the middle layer is in the range of 0.1 to 0.8 μg/mm 2; and a top layer selected from the group consisting of hydrophilic polymer, and combination of hydrophilic polymer and antioxidant; wherein the mTOR inhibitor concentration over the medical device is in the range of 0.7 to 3.00 μg/mm 2 a base layer comprising mTOR inhibitor, and a blend of biodegradable polymers, wherein the mTOR inhibitor concentration for the base layer is in the range of 0.6 to 2.2 μg/mm 2; a middle layer comprising mTOR inhibitor, and a blend of biodegradable polymers,_wherein the mTOR inhibitor concentration for the middle layer is in the range of 0.1 to 0.8 μg/mm 2; and a top layer selected from the group consisting of hydrophilic polymer, and combination of hydrophilic polymer and antioxidant; wherein the mTOR inhibitor concentration over the medical device is in the range of 0.7 to 3.00 μg/mm 2
A polypeptide having beta-lactamase activity, which comprises an amino acid sequence having at least 85 % sequence identity to SEQ ID NO:1, said polypeptide comprising: - a substitution at each of positions 10 and 22; - a substitution at each of positions 10 and 34; - a substitution at each of positions 10 and 130; - a substitution at each of positions 10, 22 and 34; - a substitution at each of positions 10, 22 and 130; - a substitution at each of positions 10, 34 and 130; or - a substitution at each of positions 10, 22, 34 and 130, wherein the positions correspond to the positions in the sequence represented in SEQ ID NO:1, and wherein said polypeptide has an improved property with respect to stability as compared with wild-type VIM-2 of SEQ ID NO:1. - a substitution at each of positions 10 and 22; - a substitution at each of positions 10 and 34; - a substitution at each of positions 10 and 130; - a substitution at each of positions 10, 22 and 34; - a substitution at each of positions 10, 22 and 130; - a substitution at each of positions 10, 34 and 130; or - a substitution at each of positions 10, 22, 34 and 130,
A composition comprising: a bacterial powder; a fatty oil; and at least one selected from the group consisting of a microscopic powder and a surfactant, wherein the microscopic powder contains at least one selected from the group consisting of microcrystalline cellulose and tricalcium phosphate, wherein the fatty oil is contained in an amount of 90 mass% or more, based on the total mass of the composition, and wherein the surfactant contains at least one selected from the group consisting of an anionic surfactant and a nonionic surfactant having an HLB value of less than 7. a bacterial powder; a fatty oil; and at least one selected from the group consisting of a microscopic powder and a surfactant, wherein the microscopic powder contains at least one selected from the group consisting of microcrystalline cellulose and tricalcium phosphate, wherein the fatty oil is contained in an amount of 90 mass% or more, based on the total mass of the composition, and wherein the surfactant contains at least one selected from the group consisting of an anionic surfactant and a nonionic surfactant having an HLB value of less than 7.
A near infrared spectrometer for sensing tissue oxygen measurements in body tissue, comprising: a plurality of light sources configured to emit broadband, near infrared measurement light into body tissue; a mixer such that the plurality of light sources emit the measurement light into the mixer without first passing through an interference filter prior to entry into the mixer; at least one temperature sensor (24, 54) configured to sense at least one temperature of the plurality of lights sources; at least one broadband photodetector configured for sensing at least a portion of the measurement light reflected back from the body tissue; and a processor configured to: model light attenuations within the body tissue based at least in part on the at least one sensed temperature; predict at least one light attenuation value within the body tissue based on the modeled light attenuations; and estimate at least one tissue chromophore concentration within the body tissue by comparing attenuations of the sensed measurement light reflected back from the body tissue to the at least one predicted light attenuation value. a plurality of light sources configured to emit broadband, near infrared measurement light into body tissue; a mixer such that the plurality of light sources emit the measurement light into the mixer without first passing through an interference filter prior to entry into the mixer; at least one temperature sensor (24, 54) configured to sense at least one temperature of the plurality of lights sources; at least one broadband photodetector configured for sensing at least a portion of the measurement light reflected back from the body tissue; and a processor configured to: model light attenuations within the body tissue based at least in part on the at least one sensed temperature; predict at least one light attenuation value within the body tissue based on the modeled light attenuations; and estimate at least one tissue chromophore concentration within the body tissue by comparing attenuations of the sensed measurement light reflected back from the body tissue to the at least one predicted light attenuation value. model light attenuations within the body tissue based at least in part on the at least one sensed temperature; predict at least one light attenuation value within the body tissue based on the modeled light attenuations; and estimate at least one tissue chromophore concentration within the body tissue by comparing attenuations of the sensed measurement light reflected back from the body tissue to the at least one predicted light attenuation value.
A composition comprising: a suspension including mammalian dental pulp stem cells, mammalian dental pulp proteins, and extracellular matrix proteins; wherein (i) the suspension is in a form that is injectable into pathologic or injured tissue; (ii) the mammalian dental pulp stem cells, mammalian dental pulp proteins and extracellular matrix proteins are derived from mammalian dental pulp; and (iii) the mammalian dental pulp has been physically disrupted, without isolation of stem cells, to prepare the suspension. a suspension including mammalian dental pulp stem cells, mammalian dental pulp proteins, and extracellular matrix proteins; wherein (i) the suspension is in a form that is injectable into pathologic or injured tissue; (ii) the mammalian dental pulp stem cells, mammalian dental pulp proteins and extracellular matrix proteins are derived from mammalian dental pulp; and (iii) the mammalian dental pulp has been physically disrupted, without isolation of stem cells, to prepare the suspension.